APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor VIIa

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Coagulation Factor VIIa Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchCoagulation Factor VIIa Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor VIIa Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Coagulation Factor VIIa Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor VIIa Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor VIIa Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Coagulation Factor VIIa market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Coagulation Factor VIIa is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Coagulation Factor VIIa is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Coagulation Factor VIIa is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Coagulation Factor VIIa is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Coagulation Factor VIIa include Novo Nordisk, LFB SA HEMA Biologics, GENERIUM and AryoGen Pharmed, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Coagulation Factor VIIa, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Coagulation Factor VIIa, also provides the sales of main regions and countries. Of the upcoming market potential for Coagulation Factor VIIa, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coagulation Factor VIIa sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Coagulation Factor VIIa market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Coagulation Factor VIIa sales, projected growth trends, production technology, application and end-user industry.

Coagulation Factor VIIa Segment by Company

Novo Nordisk

LFB SA HEMA Biologics

GENERIUM

AryoGen Pharmed

Coagulation Factor VIIa Segment by Type

Prefilled Syringe

Vial

Coagulation Factor VIIa Segment by Application

Congenital Hemophilia

Acquired Hemophilia

Other

Coagulation Factor VIIa Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor VIIa market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor VIIa and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor VIIa.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Coagulation Factor VIIa in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coagulation Factor VIIa sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coagulation Factor VIIa Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prefilled Syringe Major Manufacturers Table 3. Vial Major Manufacturers Table 4. Global Coagulation Factor VIIa Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Congenital Hemophilia Major Manufacturers Table 6. Acquired Hemophilia Major Manufacturers Table 7. Other Major Manufacturers Table 8. Coagulation Factor VIIa Industry Trends Table 9. Coagulation Factor VIIa Industry Drivers Table 10. Coagulation Factor VIIa Industry Opportunities and Challenges Table 11. Coagulation Factor VIIa Industry Restraints Table 12. Global Coagulation Factor VIIa Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Coagulation Factor VIIa Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Coagulation Factor VIIa Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Coagulation Factor VIIa Revenue Market Share by Region (2021-2026) Table 16. Global Coagulation Factor VIIa Revenue Market Share by Region (2027-2032) Table 17. Global Coagulation Factor VIIa Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 18. Global Coagulation Factor VIIa Sales by Region (2021-2026) & (tons) Table 19. Global Coagulation Factor VIIa Sales by Region (2027-2032) & (tons) Table 20. Global Coagulation Factor VIIa Sales Market Share by Region (2021-2026) Table 21. Global Coagulation Factor VIIa Sales Market Share by Region (2027-2032) Table 22. Global Coagulation Factor VIIa Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Coagulation Factor VIIa Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Coagulation Factor VIIa Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Coagulation Factor VIIa Sales Market Share by Manufacturers (2021-2026) Table 26. Global Coagulation Factor VIIa Sales Price (US$/kg) of Manufacturers (2021-2026) Table 27. Global Coagulation Factor VIIa Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Coagulation Factor VIIa Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Coagulation Factor VIIa Manufacturers, Product Type & Application Table 30. Global Coagulation Factor VIIa Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Coagulation Factor VIIa by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Coagulation Factor VIIa Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Coagulation Factor VIIa Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Coagulation Factor VIIa Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Coagulation Factor VIIa Revenue Market Share by Type (2021-2026) Table 37. Global Coagulation Factor VIIa Revenue Market Share by Type (2027-2032) Table 38. Global Coagulation Factor VIIa Sales by Type 2021 VS 2025 VS 2032 (tons) Table 39. Global Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 40. Global Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 41. Global Coagulation Factor VIIa Sales Market Share by Type (2021-2026) Table 42. Global Coagulation Factor VIIa Sales Market Share by Type (2027-2032) Table 43. Global Coagulation Factor VIIa Price by Type (2021-2026) & (US$/kg) Table 44. Global Coagulation Factor VIIa Price by Type (2027-2032) & (US$/kg) Table 45. Global Coagulation Factor VIIa Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Coagulation Factor VIIa Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Coagulation Factor VIIa Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Coagulation Factor VIIa Revenue Market Share by Application (2021-2026) Table 49. Global Coagulation Factor VIIa Revenue Market Share by Application (2027-2032) Table 50. Global Coagulation Factor VIIa Sales by Application 2021 VS 2025 VS 2032 (tons) Table 51. Global Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 52. Global Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 53. Global Coagulation Factor VIIa Sales Market Share by Application (2021-2026) Table 54. Global Coagulation Factor VIIa Sales Market Share by Application (2027-2032) Table 55. Global Coagulation Factor VIIa Price by Application (2021-2026) & (US$/kg) Table 56. Global Coagulation Factor VIIa Price by Application (2027-2032) & (US$/kg) Table 57. Novo Nordisk Company Information Table 58. Novo Nordisk Business Overview Table 59. Novo Nordisk Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 60. Novo Nordisk Coagulation Factor VIIa Product Portfolio Table 61. Novo Nordisk Recent Development Table 62. LFB SA HEMA Biologics Company Information Table 63. LFB SA HEMA Biologics Business Overview Table 64. LFB SA HEMA Biologics Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio Table 66. LFB SA HEMA Biologics Recent Development Table 67. GENERIUM Company Information Table 68. GENERIUM Business Overview Table 69. GENERIUM Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. GENERIUM Coagulation Factor VIIa Product Portfolio Table 71. GENERIUM Recent Development Table 72. AryoGen Pharmed Company Information Table 73. AryoGen Pharmed Business Overview Table 74. AryoGen Pharmed Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. AryoGen Pharmed Coagulation Factor VIIa Product Portfolio Table 76. AryoGen Pharmed Recent Development Table 77. North America Coagulation Factor VIIa Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Coagulation Factor VIIa Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 80. North America Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 81. North America Coagulation Factor VIIa Sales Price by Type (2021-2026) & (US$/kg) Table 82. North America Coagulation Factor VIIa Sales Price by Type (2027-2032) & (US$/kg) Table 83. North America Coagulation Factor VIIa Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Coagulation Factor VIIa Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 86. North America Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 87. North America Coagulation Factor VIIa Sales Price by Application (2021-2026) & (US$/kg) Table 88. North America Coagulation Factor VIIa Sales Price by Application (2027-2032) & (US$/kg) Table 89. North America Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Coagulation Factor VIIa Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Coagulation Factor VIIa Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 93. North America Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 94. North America Coagulation Factor VIIa Sales by Country (2027-2032) & (tons) Table 95. North America Coagulation Factor VIIa Sales Price by Country (2021-2026) & (US$/kg) Table 96. North America Coagulation Factor VIIa Sales Price by Country (2027-2032) & (US$/kg) Table 97. United States Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 98. Canada Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 99. Mexico Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 100. Europe Coagulation Factor VIIa Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Coagulation Factor VIIa Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 103. Europe Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 104. Europe Coagulation Factor VIIa Sales Price by Type (2021-2026) & (US$/kg) Table 105. Europe Coagulation Factor VIIa Sales Price by Type (2027-2032) & (US$/kg) Table 106. Europe Coagulation Factor VIIa Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Coagulation Factor VIIa Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 109. Europe Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 110. Europe Coagulation Factor VIIa Sales Price by Application (2021-2026) & (US$/kg) Table 111. Europe Coagulation Factor VIIa Sales Price by Application (2027-2032) & (US$/kg) Table 112. Europe Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Coagulation Factor VIIa Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Coagulation Factor VIIa Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 116. Europe Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 117. Europe Coagulation Factor VIIa Sales by Country (2027-2032) & (tons) Table 118. Europe Coagulation Factor VIIa Sales Price by Country (2021-2026) & (US$/kg) Table 119. Europe Coagulation Factor VIIa Sales Price by Country (2027-2032) & (US$/kg) Table 120. Germany Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 121. France Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 122. U.K. Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 123. Italy Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 124. Russia Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 125. Spain Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 127. Switzerland Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 128. Sweden Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 129. Poland Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 130. China Coagulation Factor VIIa Revenue by Type (2021-2026) & (US$ Million) Table 131. China Coagulation Factor VIIa Revenue by Type (2027-2032) & (US$ Million) Table 132. China Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 133. China Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 134. China Coagulation Factor VIIa Sales Price by Type (2021-2026) & (US$/kg) Table 135. China Coagulation Factor VIIa Sales Price by Type (2027-2032) & (US$/kg) Table 136. China Coagulation Factor VIIa Revenue by Application (2021-2026) & (US$ Million) Table 137. China Coagulation Factor VIIa Revenue by Application (2027-2032) & (US$ Million) Table 138. China Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 139. China Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 140. China Coagulation Factor VIIa Sales Price by Application (2021-2026) & (US$/kg) Table 141. China Coagulation Factor VIIa Sales Price by Application (2027-2032) & (US$/kg) Table 142. Asia Coagulation Factor VIIa Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Coagulation Factor VIIa Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 145. Asia Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 146. Asia Coagulation Factor VIIa Sales Price by Type (2021-2026) & (US$/kg) Table 147. Asia Coagulation Factor VIIa Sales Price by Type (2027-2032) & (US$/kg) Table 148. Asia Coagulation Factor VIIa Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Coagulation Factor VIIa Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 151. Asia Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 152. Asia Coagulation Factor VIIa Sales Price by Application (2021-2026) & (US$/kg) Table 153. Asia Coagulation Factor VIIa Sales Price by Application (2027-2032) & (US$/kg) Table 154. Asia Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Coagulation Factor VIIa Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Coagulation Factor VIIa Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 158. Asia Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 159. Asia Coagulation Factor VIIa Sales by Country (2027-2032) & (tons) Table 160. Asia Coagulation Factor VIIa Sales Price by Country (2021-2026) & (US$/kg) Table 161. Asia Coagulation Factor VIIa Sales Price by Country (2027-2032) & (US$/kg) Table 162. Japan Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 163. South Korea Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 164. India Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 165. Australia Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 166. Taiwan Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Coagulation Factor VIIa Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Coagulation Factor VIIa Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 171. SAMEA Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 172. SAMEA Coagulation Factor VIIa Sales Price by Type (2021-2026) & (US$/kg) Table 173. SAMEA Coagulation Factor VIIa Sales Price by Type (2027-2032) & (US$/kg) Table 174. SAMEA Coagulation Factor VIIa Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Coagulation Factor VIIa Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 177. SAMEA Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 178. SAMEA Coagulation Factor VIIa Sales Price by Application (2021-2026) & (US$/kg) Table 179. SAMEA Coagulation Factor VIIa Sales Price by Application (2027-2032) & (US$/kg) Table 180. SAMEA Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Coagulation Factor VIIa Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Coagulation Factor VIIa Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 184. SAMEA Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 185. SAMEA Coagulation Factor VIIa Sales by Country (2027-2032) & (tons) Table 186. SAMEA Coagulation Factor VIIa Sales Price by Country (2021-2026) & (US$/kg) Table 187. SAMEA Coagulation Factor VIIa Sales Price by Country (2027-2032) & (US$/kg) Table 188. Brazil Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 189. Argentina Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 190. Chile Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 191. Colombia Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 192. Peru Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 194. Israel Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 195. UAE Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 196. Turkey Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 197. Iran Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 198. Egypt Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Coagulation Factor VIIa Distributors List Table 202. Coagulation Factor VIIa Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Coagulation Factor VIIa Image Figure 2. Global Coagulation Factor VIIa Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor VIIa Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prefilled Syringe Image Figure 5. Vial Image Figure 6. Global Coagulation Factor VIIa Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Coagulation Factor VIIa Market Size Share 2021 VS 2025 VS 2032 Figure 8. Congenital Hemophilia Image Figure 9. Acquired Hemophilia Image Figure 10. Other Image Figure 11. Global Coagulation Factor VIIa Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Coagulation Factor VIIa Revenue (2021-2032) & (US$ Million) Figure 13. Global Coagulation Factor VIIa Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Coagulation Factor VIIa Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Coagulation Factor VIIa Revenue Market Share by Region (2021-2032) Figure 16. Global Coagulation Factor VIIa Sales (2021-2032) & (tons) Figure 17. Global Coagulation Factor VIIa Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 18. Global Coagulation Factor VIIa Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Coagulation Factor VIIa Sales YoY (2021-2032) & (tons) Figure 20. Europe Coagulation Factor VIIa Sales YoY (2021-2032) & (tons) Figure 21. China Coagulation Factor VIIa Sales YoY (2021-2032) & (tons) Figure 22. Asia (Excluding China) Coagulation Factor VIIa Sales YoY (2021-2032) & (tons) Figure 23. South America, Middle East and Africa Coagulation Factor VIIa Sales YoY (2021-2032) & (tons) Figure 24. Global Coagulation Factor VIIa Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Coagulation Factor VIIa Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Coagulation Factor VIIa Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Coagulation Factor VIIa Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Coagulation Factor VIIa Revenue Market Share by Type (2021-2032) Figure 30. Global Coagulation Factor VIIa Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 31. Global Coagulation Factor VIIa Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Coagulation Factor VIIa Sales Market Share by Type (2021-2032) Figure 33. Global Coagulation Factor VIIa Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Coagulation Factor VIIa Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Coagulation Factor VIIa Revenue Market Share by Application (2021-2032) Figure 36. Global Coagulation Factor VIIa Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 37. Global Coagulation Factor VIIa Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Coagulation Factor VIIa Sales Market Share by Application (2021-2032) Figure 39. North America Coagulation Factor VIIa Revenue Share by Type (2021-2032) Figure 40. North America Coagulation Factor VIIa Sales Share by Type (2021-2032) Figure 41. North America Coagulation Factor VIIa Revenue Share by Application (2021-2032) Figure 42. North America Coagulation Factor VIIa Sales Share by Application (2021-2032) Figure 43. North America Coagulation Factor VIIa Revenue Share by Country (2021-2032) Figure 44. North America Coagulation Factor VIIa Sales Share by Country (2021-2032) Figure 45. Europe Coagulation Factor VIIa Revenue Share by Type (2021-2032) Figure 46. Europe Coagulation Factor VIIa Sales Share by Type (2021-2032) Figure 47. Europe Coagulation Factor VIIa Revenue Share by Application (2021-2032) Figure 48. Europe Coagulation Factor VIIa Sales Share by Application (2021-2032) Figure 49. Europe Coagulation Factor VIIa Revenue Share by Country (2021-2032) Figure 50. Europe Coagulation Factor VIIa Sales Share by Country (2021-2032) Figure 51. China Coagulation Factor VIIa Revenue Share by Type (2021-2032) Figure 52. China Coagulation Factor VIIa Sales Share by Type (2021-2032) Figure 53. China Coagulation Factor VIIa Revenue Share by Application (2021-2032) Figure 54. China Coagulation Factor VIIa Sales Share by Application (2021-2032) Figure 55. Asia Coagulation Factor VIIa Revenue Share by Type (2021-2032) Figure 56. Asia Coagulation Factor VIIa Sales Share by Type (2021-2032) Figure 57. Asia Coagulation Factor VIIa Revenue Share by Application (2021-2032) Figure 58. Asia Coagulation Factor VIIa Sales Share by Application (2021-2032) Figure 59. Asia Coagulation Factor VIIa Revenue Share by Country (2021-2032) Figure 60. Asia Coagulation Factor VIIa Sales Share by Country (2021-2032) Figure 61. SAMEA Coagulation Factor VIIa Revenue Share by Type (2021-2032) Figure 62. SAMEA Coagulation Factor VIIa Sales Share by Type (2021-2032) Figure 63. SAMEA Coagulation Factor VIIa Revenue Share by Application (2021-2032) Figure 64. SAMEA Coagulation Factor VIIa Sales Share by Application (2021-2032) Figure 65. SAMEA Coagulation Factor VIIa Revenue Share by Country (2021-2032) Figure 66. SAMEA Coagulation Factor VIIa Sales Share by Country (2021-2032) Figure 67. Coagulation Factor VIIa Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Coagulation Factor VIIa Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Prefilled Syringe
  • Vial
Applications
  • Congenital Hemophilia
  • Acquired Hemophilia
  • Other
Companies covered
  • Novo Nordisk
  • LFB SA HEMA Biologics
  • GENERIUM
  • AryoGen Pharmed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Coagulation Factor VIIa Market by Type
  3. 1.2.1 Global Coagulation Factor VIIa Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prefilled Syringe
  5. 1.2.3 Vial
  6. 1.3 Coagulation Factor VIIa Market by Application
  7. 1.3.1 Global Coagulation Factor VIIa Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Congenital Hemophilia
  9. 1.3.3 Acquired Hemophilia
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Coagulation Factor VIIa Market Dynamics
  1. 2.1 Coagulation Factor VIIa Industry Trends
  2. 2.2 Coagulation Factor VIIa Industry Drivers
  3. 2.3 Coagulation Factor VIIa Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor VIIa Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Coagulation Factor VIIa Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Coagulation Factor VIIa Revenue by Region
  3. 3.2.1 Global Coagulation Factor VIIa Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Coagulation Factor VIIa Revenue by Region (2021-2026)
  5. 3.2.3 Global Coagulation Factor VIIa Revenue by Region (2027-2032)
  6. 3.2.4 Global Coagulation Factor VIIa Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Coagulation Factor VIIa Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Coagulation Factor VIIa Sales by Region
  9. 3.4.1 Global Coagulation Factor VIIa Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Coagulation Factor VIIa Sales by Region (2021-2026)
  11. 3.4.3 Global Coagulation Factor VIIa Sales by Region (2027-2032)
  12. 3.4.4 Global Coagulation Factor VIIa Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Coagulation Factor VIIa Revenue by Manufacturers
  2. 4.1.1 Global Coagulation Factor VIIa Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Coagulation Factor VIIa Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Coagulation Factor VIIa Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Coagulation Factor VIIa Sales by Manufacturers
  6. 4.2.1 Global Coagulation Factor VIIa Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Coagulation Factor VIIa Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Coagulation Factor VIIa Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Coagulation Factor VIIa Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Coagulation Factor VIIa Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Coagulation Factor VIIa Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Coagulation Factor VIIa Manufacturers, Product Type & Application
  13. 4.7 Global Coagulation Factor VIIa Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Coagulation Factor VIIa Market CR5 and HHI
  16. 4.8.2 2025 Coagulation Factor VIIa Tier 1, Tier 2, and Tier 3
5 Coagulation Factor VIIa Market by Type
  1. 5.1 Global Coagulation Factor VIIa Revenue by Type
  2. 5.1.1 Global Coagulation Factor VIIa Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Coagulation Factor VIIa Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Coagulation Factor VIIa Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Coagulation Factor VIIa Sales by Type
  6. 5.2.1 Global Coagulation Factor VIIa Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coagulation Factor VIIa Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Coagulation Factor VIIa Sales Market Share by Type (2021-2032)
  9. 5.3 Global Coagulation Factor VIIa Price by Type
6 Coagulation Factor VIIa Market by Application
  1. 6.1 Global Coagulation Factor VIIa Revenue by Application
  2. 6.1.1 Global Coagulation Factor VIIa Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Coagulation Factor VIIa Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Coagulation Factor VIIa Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Coagulation Factor VIIa Sales by Application
  6. 6.2.1 Global Coagulation Factor VIIa Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Coagulation Factor VIIa Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Coagulation Factor VIIa Sales Market Share by Application (2021-2032)
  9. 6.3 Global Coagulation Factor VIIa Price by Application
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk Coagulation Factor VIIa Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 LFB SA HEMA Biologics
  8. 7.2.1 LFB SA HEMA Biologics Company Information
  9. 7.2.2 LFB SA HEMA Biologics Business Overview
  10. 7.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio
  12. 7.2.5 LFB SA HEMA Biologics Recent Developments
  13. 7.3 GENERIUM
  14. 7.3.1 GENERIUM Company Information
  15. 7.3.2 GENERIUM Business Overview
  16. 7.3.3 GENERIUM Coagulation Factor VIIa Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GENERIUM Coagulation Factor VIIa Product Portfolio
  18. 7.3.5 GENERIUM Recent Developments
  19. 7.4 AryoGen Pharmed
  20. 7.4.1 AryoGen Pharmed Company Information
  21. 7.4.2 AryoGen Pharmed Business Overview
  22. 7.4.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AryoGen Pharmed Coagulation Factor VIIa Product Portfolio
  24. 7.4.5 AryoGen Pharmed Recent Developments
8 North America
  1. 8.1 North America Coagulation Factor VIIa Market Size by Type
  2. 8.1.1 North America Coagulation Factor VIIa Revenue by Type (2021-2032)
  3. 8.1.2 North America Coagulation Factor VIIa Sales by Type (2021-2032)
  4. 8.1.3 North America Coagulation Factor VIIa Price by Type (2021-2032)
  5. 8.2 North America Coagulation Factor VIIa Market Size by Application
  6. 8.2.1 North America Coagulation Factor VIIa Revenue by Application (2021-2032)
  7. 8.2.2 North America Coagulation Factor VIIa Sales by Application (2021-2032)
  8. 8.2.3 North America Coagulation Factor VIIa Price by Application (2021-2032)
  9. 8.3 North America Coagulation Factor VIIa Market Size by Country
  10. 8.3.1 North America Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Coagulation Factor VIIa Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Coagulation Factor VIIa Market Size by Type
  2. 9.1.1 Europe Coagulation Factor VIIa Revenue by Type (2021-2032)
  3. 9.1.2 Europe Coagulation Factor VIIa Sales by Type (2021-2032)
  4. 9.1.3 Europe Coagulation Factor VIIa Price by Type (2021-2032)
  5. 9.2 Europe Coagulation Factor VIIa Market Size by Application
  6. 9.2.1 Europe Coagulation Factor VIIa Revenue by Application (2021-2032)
  7. 9.2.2 Europe Coagulation Factor VIIa Sales by Application (2021-2032)
  8. 9.2.3 Europe Coagulation Factor VIIa Price by Application (2021-2032)
  9. 9.3 Europe Coagulation Factor VIIa Market Size by Country
  10. 9.3.1 Europe Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Coagulation Factor VIIa Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Coagulation Factor VIIa Market Size by Type
  2. 10.1.1 China Coagulation Factor VIIa Revenue by Type (2021-2032)
  3. 10.1.2 China Coagulation Factor VIIa Sales by Type (2021-2032)
  4. 10.1.3 China Coagulation Factor VIIa Price by Type (2021-2032)
  5. 10.2 China Coagulation Factor VIIa Market Size by Application
  6. 10.2.1 China Coagulation Factor VIIa Revenue by Application (2021-2032)
  7. 10.2.2 China Coagulation Factor VIIa Sales by Application (2021-2032)
  8. 10.2.3 China Coagulation Factor VIIa Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Coagulation Factor VIIa Market Size by Type
  2. 11.1.1 Asia Coagulation Factor VIIa Revenue by Type (2021-2032)
  3. 11.1.2 Asia Coagulation Factor VIIa Sales by Type (2021-2032)
  4. 11.1.3 Asia Coagulation Factor VIIa Price by Type (2021-2032)
  5. 11.2 Asia Coagulation Factor VIIa Market Size by Application
  6. 11.2.1 Asia Coagulation Factor VIIa Revenue by Application (2021-2032)
  7. 11.2.2 Asia Coagulation Factor VIIa Sales by Application (2021-2032)
  8. 11.2.3 Asia Coagulation Factor VIIa Price by Application (2021-2032)
  9. 11.3 Asia Coagulation Factor VIIa Market Size by Country
  10. 11.3.1 Asia Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Coagulation Factor VIIa Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Coagulation Factor VIIa Market Size by Type
  2. 12.1.1 SAMEA Coagulation Factor VIIa Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Coagulation Factor VIIa Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Coagulation Factor VIIa Price by Type (2021-2032)
  5. 12.2 SAMEA Coagulation Factor VIIa Market Size by Application
  6. 12.2.1 SAMEA Coagulation Factor VIIa Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Coagulation Factor VIIa Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Coagulation Factor VIIa Price by Application (2021-2032)
  9. 12.3 SAMEA Coagulation Factor VIIa Market Size by Country
  10. 12.3.1 SAMEA Coagulation Factor VIIa Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Coagulation Factor VIIa Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Coagulation Factor VIIa Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Coagulation Factor VIIa Value Chain Analysis
  2. 13.1.1 Coagulation Factor VIIa Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Coagulation Factor VIIa Production Mode & Process
  6. 13.2 Coagulation Factor VIIa Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Coagulation Factor VIIa Distributors
  9. 13.2.3 Coagulation Factor VIIa Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst